Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
Nov 22 NVO “No magic wand” for Novo Nordisk, as CagriSema pen supply rumours swirl
Nov 22 NVO Novo Nordisk Plunges 25% in 3 Months: How to Play the Stock
Nov 22 NVO Barclays says buy Novo Nordisk stock 'into this critically important catalyst'
Nov 22 NVO RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?
Nov 22 NVO Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pens
Nov 22 NVO Oura rings to track blood sugar, Vaccines vs RFK Jr., and Ozempic 2.0: Pharma news roundup
Nov 21 NVO The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock.
Nov 21 TNDM Tandem Diabetes Care Announces Upcoming Conference Presentations
Nov 21 NVO Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Nov 21 NVO Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU
Nov 21 NVO Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
Nov 20 NVO More companies covering weight loss drugs for their employees
Nov 20 NVO Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
Nov 20 NVO Is Novo Nordisk Stock a Buy Right Now?
Nov 20 NVO RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.
Nov 19 NVO Novo Nordisk semaglutide phase 3 trial for MASH meets primary endpoints
Nov 19 EHAB Enhabit Announces Participation in Upcoming BofA Home Care Conference
Nov 19 NVO Sector Update: Health Care Stocks Decline
Nov 19 NVO Novo Nordisk Unusual Options Activity For November 19
Nov 19 NVO Sector Update: Health Care Stocks Mixed Tuesday Afternoon
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags